相关实验视频

Updated: Jun 29, 2025

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

梅齐多米德-一种新型的Cereblon E3酶调节器正在复发性/反射性多发性髓瘤中进行研究

Monique A Hartley-Brown¹, Clifton C Mo¹, Omar Nadeem¹

¹Department of Medical Oncology, Dana-Farber Cancer Institute, Jerome Lipper Center for Multiple Myeloma Research, Harvard Medical School, 450 Brookline Avenue, Dana 1B02, Boston, MA 02115, USA.

|March 28, 2024

概括

梅西戈米德是一种新型的大脑 E3 酶调节剂 (CELMoD),通过降解关键蛋白质,表现出强大的抗髓瘤活性. 临床试验表明,在复发性/耐药性多发性骨髓瘤患者中具有有希望的疗效.

科学领域:

在瘤学瘤学.
药理学药理学是指药理学的学科.
分子生物学分子生物学

背景情况:

多发性骨髓瘤 (MM) 是一种血液性恶性瘤,在复发性/耐药性 (RR) 环境中有未满足的需求.
塞雷布隆E3酶调节剂 (CELMoDs) 是一种针对MM的新型治疗类.
了解梅西戈米德的机制和临床概况对于推进MM治疗至关重要.

研究的目的:

为了审查梅西戈米德的临床前和临床发现,CELMoD.
评估梅西戈米德在复发性/耐药性多发性骨髓瘤 (RRMM) 的疗效和安全性.
讨论梅西戈米德在MM治疗中的潜在未来作用.

主要方法:

临床前研究评估了梅西戈米德的抗增殖,亡和免疫刺激作用.
与其他抗髓瘤药物的协同活性在体外和体内进行了评估.
早期临床试验研究了梅西戈米德在重度预治疗的RRMM患者中.

主要成果:

梅西戈米德显示强烈的结合cereblon和降解Ikaros和Aiolos.
临床前模型显示抗髓瘤活性,免疫刺激和与其他药物的协同作用.
临床数据显示,三级耐火RRMM具有可管理的安全性.

结论:

梅西戈米德通过选择性蛋白质降解表现出强大的抗髓瘤作用.
早期的临床数据表明,在具有挑战性的RRMM种群中,具有显著的治疗潜力.
梅西戈米德是治疗多发性骨髓瘤的一种有前途的新药.

关键词:

在CELMoDs中使用的CELMoDs.这就是为什么Cereblon.梅西格多米德的使用方法多发性骨髓瘤是多发性骨髓瘤的一种.耐火材料耐火材料耐火材料这是一个复发的复发.

更多相关视频

In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells

In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells

Published on: January 20, 2019

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos

Published on: December 13, 2018

相关概念视频

Receptor Downregulation in MVBs

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...

Drugs that Stabilize Microtubules

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...